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ABSTRACT
Garcinia husor is one of the folk medicines in Maluku-Indonesia. This species has 
been used for the treatmet of Malaria disease. The phytochemical contents and 
antiplasmodial activity not reported yet. In this study we evaluated the quantitative 
phytochemicals, in vitro and in vivo antiplasmodial activity of stem bark ethyl 
acetate extract. In vitro assay was done using P. falciparum 3D7 strain sensitive 
of chloroquine. For in vivo analysis, four groups of M. musculus were infected 
by P. berghei and their parasitemia levels were for 7 days of treatment with ethyl 
acetate extract; hematological and biochemical parameter were analyzed at the 
end of experiment. The result showed ethyl acetate extract with the TPC (169.47 
mg GAE/100 g ±0.61) and TPC (167.37 mg QE/100 g ±1.05) was active against P. 
falciparum 3D7 strain (IC50 value of 0.31±0.43 μg/ml). The animal treated with 
extract showed suppression of parasitemia to 87.57±1.41% compared with the 
P. berghei infected-mice (negative control), ED50 value of 22.30 mg/kg BW. The 
dose of extract in 200 mg/kg BW was reduce parasitemia of infected mice with 
P. berghei more potential. The ethyl acetate of the stem bark G. husor with has 
antiplasmodial properties and future investigation are necessary to elucidate its 
mechanism of action.
ARTICLE INFO
Article history:
Received July 18, 2018
Received in revised form September 18, 2018
Accepted February 1, 2019
KEYWORDS:
Antiplasmodial, 
Garcinia, 
parasitemia, 
P. berghei, 
P. palcifarum
* Corresponding Author
 E-mail Address: paktichem@gmail.com
Copyright ©2019 Institut Pertanian Bogor 
 Vol. 26 No. 2, April 2019 81-89
DOI:10.4308/hjb.26.2.81
ISSN: 1978-3019
EISSN: 2086-4094
1. Introduction
Malaria is a major infectious disease with a high 
mortality in the developing country (Boampong et 
al. 2015). Until now, efforts have been made to treat 
this disease related to the development of alternative 
antimalarial, due to the emergence of drug-resistant 
strain. Many plants are used therapeutically in 
alternative and traditional medicine to treat 
infectious diseases. New and safe antimalarial 
drugs are urgently needed and natural products can 
represent a vast source of leading molecules (Oliveira 
et al. 2014). 
Garcinia species are known to contain phenolic 
compounds such as xanthones, benzophenones, 
flavones, and depsidone (Nilar et al. 2005). Phenolic 
compounds showed that a wide range of biological 
and pharmacological properties, e.g. antioxidant, 
anti-inflammatory, antimicrobial, antiplasmodial, 
and cytotoxic activities (Minami  et al. 1994; Vlientinck 
et al. 1998; Merza et al. 2006; Cos et al. 2008; Chin 
et al. 2008; Elfita et al. 2009). Benzophenones 
have been reported as anti-HIV, trypanocidal and 
cytotoxic agents (Gustafson et al. 1992; Vlietinck et 
al. 1998; Williams et al. 2003; Merza et al. 2006; Cos 
et al. 2008).
Garcinia husor (locally named ‘‘manggustan 
hutan” in Indonesia) is a medium sized tree ocurring 
in Maluku. In some Maluku communities, the stem 
bark of G. husor used in the treatment of malaria 
as endemic area but this has not been scientifically 
verified. This study was designed to evaluate the 
antimalarial potential of the ethyl acetate extract 
stem bark G. husor  using Plasmodium falcifarum D37 
strain in vitro and in vivo at P. berghei infected mice 
model.
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2. Materials and Methods
2.1. Plant Material 
The stem bark of G. husor was collected from 
Allane Forest at Ambon island, Indonesia. This plant 
was identified and a voucher specimen (No. 52) was 
deposited at Biology Laboratory of Biology Departement, 
Pattimura University, Indonesia.
2.2. Preparation of Extract
The stem bark of G. husor were dried at room 
temperature and reduced to coarse powder using a 
disk mill SMJMA, FFC-15, Shandong Jimo. Dried stem 
bark powder (500 g) was mixed ethyl acetate and 
filtered. The solvent was evaporated under reduce 
pressure (Rotavapor R-210, Buchi, Switzerland) to 
obtain a solid mass extract of ethyl acetate (13.3% 
w/w). 
2.3. Screening for Secondary Metabolites 
The ethyl acetate extract was screened for 
the presence of phytochemicals using standard 
procedures described elsewhere (Njoku and Obi 
2009; Khan et al. 2011; Tiwari et al. 2011).
2.4. Determination of TPC and TFC 
Total phenolic and flavonoid contents were 
determined by Folin-Ciocalteu’s and aluminium 
chloride colometric methods, respectively (Singh 
et al. 2013) following quantification on the basis of 
standard curve of gallic acid (GAE) and quercetin 
(QE) equivalent, respectively. 
2.5. Antimalarial Assays
2.5.1. In Vitro Test
The antimalarial activity of the extract was 
determined by the procedure described by 
Widyawaruyanti et al. 2007. In brief, extract dissolved 
in DMSO (10-2 mol L-1) and kept at -20oC until used. 
The malarial parasite P. falciparum 3D7 clone was 
propagated in a 24-well culture plate in the presence 
of a wide range of concentrations of each compound. 
The growth of the parasite was monitored by making 
a blood smear fixed with MeOH and stained with 
Geimsa stain.
Based on percent inhibition data, an analysis was 
conducted between the concentration of the test 
and the percent inhibition using probit log analysis 
to determine the IC50 value or concentration of the 
extract which could inhibit parasite growth by 50%. 
2.5.2. In Vivo Tests
Animals and husbandry M. musculus weighing 20-
24 g were obtained from Biology Laboratory Pattimura 
University, Indonesia. The animal were housed in 
stainless steel cages (34 x 47 x 18 cm) with soft wood 
shaving as bedding, fed with normal commercial pellet 
diet given water ad libitum and maintaned under 
ambient laboratory conditions. All procedures and 
techniques used in these studies were in accordance 
with the National Institute of health Guidelines for 
the Care and Use of Laboratory Animals (NRC 1996). 
All ethical protocols used for the study were approved 
by the Departemental Ethics Committe.
2.5.2.1. Animals
Four-week-old M. Musculus from the Zoology 
Laboratory of Pattimura University were used in the 
experiments. Prior to the experimental produres, the 
animals were kept at 22±2oC on a 12 h dark-light, 
with balanced feed and water ad libitum for 15 days. 
All experiments were conducted in accordance with 
the internationally accepted principles for laboratory 
animal use and care adopted by the Animal Use Ethics 
committe of Airlangga University.
2.5.2.2. Acute Toxicity Evaluation
The acute toxicity assay was performed following 
the guidelines of The Organization for Economic 
Cooperation and Development (OCDE)-423/2001. 
When previous studies have assessed the acute toxicity 
of a known sample, the iniatial dose used can be the 
maximum dose without side effects. G. husor was tested 
in three groups of three animals each that were analyzed 
every 30 min during the first 4 h, periodically for 24 h 
and daily until the 14th day. Several parameters such as 
general activity, irritability, contortion, ataxia, tremors, 
convulsion, piloerection, hypothermia, breathing, 
cyanosis, hyperemia, and death were analyzed.
2.5.2.3. Induction of the Experimental Malaria 
Model
The malaria model was induced using the P. 
berghei ANKA (PbA) line. For the inoculation of the 
experimental groups, a blood drop from infected 
animals was collected from the terminal portion 
% growth  = % paristemia - DO
% inhibition  = 100% - ((Xu/Xk) x 100%)
Where:
DO :% growth at 0 o’clock
Xu :% growth at solution test
Xk :% growth at negative control
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of the tail to analyze parasite density. The blood 
content of animals with a parasite density higher 
than 10% in the ascent phase was collected by 
cardiac puncture using an insulin syringe washed 
with the anticoagulant agent EDTA. To guarantee 
uniform parasitemia in the different experimental 
groups, animals were infected intraperitoneally 
with a standardized inoculum of approximately 106 
parasitized erythrocytes in 100 μl PBS.
2.5.2.4. Determination of Parasite Desity and 
Parasitemic Suppression
Parasites were investigated in mouse tail blood 
smears fixed in absolute methanol for 2 min and 
stained with 10% Giemsa for 15 min. Percent 
parasitemia was determined in each animal as the 
ratio between the quantity of parasitized erythrocytes 
and the total quantity of cells (500 cells per smear):
Parasitemia was determined on the 4th days 
3. Results
3.1. Preliminari Phytochemical of Ethyl Acetate 
Extract
The qualitative and quantative phytochemical of 
ethyl acetate extract was prepared from G. husor stem 
bark. The results of preliminary tests of different 
phytochemicals extract revealed the presence of 
alkaloid, terpenoids, flavonoid, tannins, and phenolics 
(Table 1). 
The quantitative of phytochemical by determined 
of TPC (Total phenolic content) and TFC (Total 
flavonoid content) from extracts. The amount of 
total phenolic compounds present in extract was 
determined from linear regression equation of 
calibrate curve, [y= 0.0045x + 0.0481 (R2=0.9581)] 
and expressed as Gallic acid equivalent in mg/ml 
of extract. Table 1 depicts the result of assesment 
of total phenolic content in the tested extracts. It is 
found that, stem bark of G. husor (p<0.05) displayed 
high contents of total phenolics in aquoeus extracts 
showed 169.47 mg GAE/100 g ±0.61 mg GAE/100 g. 
The total flavonoid in extract was determined 
from linear regression equation of calibration 
curve obtained from the different concentration of 
quercetin [y=0.009x + 0.0161 (R2=0.983)] and the 
results was expressed as Gallic acid equivalent in mg/
ml of extract (Table 1). However, extract demonstrated 
considerably high amount of flavonoids in stem bark 
G. husor with 167.37 mg QE/100 g ±1.05 (Table 1). 
% parasitemia =
500
quantity of parasitized erythrocytes
post-inoculation of BALB/c mice with PbA line. The 
model proposed by Girma et al. (2015) was used to 
determine the suppression potential of oleoresin 
against the parasitemia rate of P. berghei-infected 
mice.
2.5.2.5. Experimental Design
Mice were randomly divided into four groups of 
3 animals each: Group 1 (G1), untreated P. berghei-
infected mice; Groups G2, G3, and G4, P. berghei-
infected mice treated orally with ethyl acetate G. 
husor stem bark extract, 10, 100, and 200 mg/kg/day, 
respectivelly. Extract was suspended with 5% CMC-Na 
as vehicle. All treatments began on the 4th day after P. 
berghei inoculation, when parasite density was first 
determined to confirm infection. For the collection 
biological material at the end of treatment, animals 
were kept on their habitual diet without fasting due 
to the fragility of the malarial state. 
2.5.2.6. Statistical Analysis
Data were analyzed statistically with Microsoft 
Excel 2010 and SPSS v22. Result were analyzed by 
ANOVA followed by LSD if significant difference. p 
value <0.05 was considered statistically significant. 
All data were expressed as mean ± SD (triplicate 
measurement). 
Table 1. Qualitative and quantitative phytochemical of 
ethyl acetate of G. husor stem bark extract
Secondary metabolites tested
Qualitative of phytochemical
Alkaloids 
Terpenoids
Flavonoids
Saponin
Phenolics
Tannins
Quatitative of phytochemical
Total phenolic content 
Total flavonoid content
Ethyl acetate extract
+
+
+
-
+
+
169.47 mg GAE/100 g ±0.61a
167.37 mg QE/100 g ±1.05b
+:present, -:undetected
a Results are expressed as gallic acid equivalents//100 g of 
extract
b Results are expressed as quercetin equivalents//100 g of 
extract
Value were performed in triplicated and represented as 
mean ± SD. Level of significance: (p<0.001)
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3.2. In Vitro Antimalarial Activity 
The in vitro assay, antimalarial activity with the 
treatment of of G. husor stem bark ethyl acetate 
extract showed a decrease in parasite percentage of 
growth according to increased concentration, 0.01 
μg/ml (3.28%); 0.1 μg/ml (2.54%); 1 μg/ml (1.74%); 10 
μg/ml (1.01%); 100 μg/ml (0.36%) (Figure 1a). Thus, 
the inhibition of parasite growth increased as the 
concentration increased, 0.01 μg/ml (22.89%); 0.1 μg/
ml (40.25%); 1 μg/ml (59.04%); 10 μg/ml (76.29%); 
100 μg/ml (91.55%) (Figure 1b). Chloroquine as a 
positive control showed 100% inhibition at 100 μg/
ml concentration and the lowest inhibition of 59.09%, 
this is equivalent to inhibition of the extract at 1 μg/
ml of concentration. Extract exhibiting IC50 value  ≤10 
μg/ml was cosidered to be active. Those exhibiting IC50 
value  in the range 10 to ≤10 μg/ml were considered 
moderately active. Extract exhibiting IC50 value 
≥10 μg/ml was considered in active (Bagavan et al. 
2011; Bunyong et al. 2014; Lima et al. 2015). Extract 
ethyl acetate potent inhibitory activity, with an IC50 
value of 0.31 μg/ml less than that antimalarial drug, 
chloroquine (IC50, 0.006 μg/ml). The inhibitory activity 
of these extract supports the traditional use of the 
dried stem bark of G. husor as an antimalarial drug.
3.3. In Vivo Antimalarial Activity
3.3.1. Acute Toxicity Evaluation
The administration of the maximum dose of ethyl 
acetate G. husor stem bark extract did not promote 
any changes such as loss of the hair or color, tremors, 
increased salivation, diarrheae, lethargy, increased or 
reduced sleep, pain or suffering, or weight loss. 
Body weight is one of indicator that shows the 
state of malaria disease. Generally, in the P. berghei-
infected state, the body weight of the mice will 
decrease as the number of infected red blood cells 
increases. Thus, by observing the weight changes of 
the mice, it is hoped to know the relationship with the 
change of parasitemia number in mice. In Table 2, P. 
berghei infection caused significant(p<0.05) decrease 
in the body weight-gain in the mice relative normal 
of all groups. All tested doses of the aquoeus extract 
significantly protected the mice from body weight 
loss. Thus it can be said that the extract is safe and 
effective as an antimalarial and does not significantly 
influence body weight loss of mice (Fentahun et al. 
2017). 
3.3.2. Quantitative Analysis of the Evaluation 
of Parasitemia
Quantitative analysis of number of parasites in 
blood samples collected on 4th day post-inocultion 
showed level growth of parasite in the mean 
presentage of G1, infected only (48.3±0.007%) 
higher than G2 (27.66±0.06%), G3 (21.66±0.01%), G4 
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Figure 1. (a) Growth (%)  and (b) Inhibition (%) of P. falcifarum 
incubated 48 hours with G. husor stem bark ethyl 
acetate extract. Value were performed in triplicated 
and represented as mean ± SD. Level of significance: 
(p<0.001)
Table 2. Effect of extract on the mean body weight in P. 
berghei infected mice
Values are given as mean ± SD (n=3) 
*Significantly different from normal (p<0.05)
Treatment
20.17±0.05
20.58±0.39
21.25±0.12
21.93±0.29
19.84±0.11
20.42±0.47
21.20±0.11
21.92±0.36
-0.32±0.06
-0.16±0.10
-0.05±0.02
-0.01±0.01
Infected only (G1)
Infected + extract 
dose10 mg/kg 
BW (G2)
Infected + extract 
dose 100 mg/
kg BW (G3)
Infected + ekstract 
dose 200 mg/
kg BW(G4)
Initial Final
Body weight (g) Changes in body 
weight (g)
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(6.0±0.01%) (Figure 2). Effects of extract on P. berghei 
infected M. musculus. The results showed that an 
average percentage of inhibition against P. berghei 
of the infected only group (G1) and the infected 
treatment extract group (G2, G3, and G4) where 
the increased of dose treatment decrease percent 
growth of parasite. This indicates higher percentage 
of inhibition G4 (87.37%) than G2 and G3. The G1 
as negative control  showed that higher growth of 
parasite (48.30±8.17%) and can not inhibit of parasite. 
So it can be said that ethyl acetate G. husor stem 
bark extract has good antimalarial activity because 
at a dose of 200 mg/kg BW showed percentage of 
inhibition ≥50% (Munoz et al. 2000).
Extract with persentage of inhibition ≥50% an in 
vivo assay at a dose of 100 mg/kg BW was classified 
as having excellent anti Plasmodium activity (Bantie 
et al. 2014; De Villiers et al. 2017). Based on this 
classification, the ethyl acetate G. husor stem bark 
extract have exelent antiplasmodial because at a 
dose of 100 mg/kg BW has been able to inhibit the 
growth parasite of P. berghei ≥50%. Furthermore, 
probit analysis obtained ED50 value ethyl acetate G. 
husor stem bark extract of  22, 30 mg/kg BW.
The results of change level parasitemia by ANOVA 
test and futher analiysis LSD showed that a significant 
difference in the mean presentage of decrease of 
parasitemia, p<0.05 G1 (0.01±0.07%), G2 (0.10±0.06%), 
G3 (0.24 ± 0.01), G4 (0.34±0.01%). The result showed 
that parasitemia was reduced in all treated groups in 
relation to untreated P. berghei-infected mice (G1) 
(Figure 3). The infected untreat extract (G1) was 
significantly different with the doses of 10 (G2), 100 
(G3), and 200 mg/kg BW (G4), the dose 10 mg/kg BW 
(G2) was not significantly different with the dose of 
100 mg/kg BW (G3), but the dose of 100 mg/kg BW 
(G3) was significantly different with a dose of 200 
mg/kg BW (G4). 
Malaria infection also causes renal damage due 
to high parasitemia, when parasitized erythrocytes 
become hard, with reduced deformability and 
changes conformation. This increases blood viscosity, 
slowing and microcirculation and altering renal blood 
flow. Additionally, the cytoadherence of infected 
erythrocytes alters the local circulation, aggravating 
the renal injury. Our result showed that treatment 
with extract may contribute to an increase in the 
microcirculation, reducing erythrocyte cytoadhence, 
with a significant decrease of parasitemia.
The level of parasitemia is obtained from thin 
blood preparation by counting the number of 
infected cells P. berghei (ring-shaped trofozoid, 
advanced stage trofozoid, and schizon) in 1000 
erythrocytes. Erythrocytes containing old trofozoites 
and schizons have obviously coarse points (Maurer's 
point) spread over two-thirds of the erythrocytes. 
The more trophozoites and schizons, the higher the 
level of parasitemia (Figure 4).
Figure 2. (a) Growth of parasite (%) and (b) inhibition parasite (%)  in M. musculus. Each bar represents the mean ± SD level parasitemia 
of animal belonging to G1 (of P. berghei infected-mice), G2 to G4 (aquoeus G. husor stem bark extract 10, 100, and 200 kg/BW), 
respectively). Significantly different (p<0.001) in level parasitemia of G1 compared to G2-G4
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4. Discussion
During the prospection of new subtances with 
antimalarial potential an important feature is required: 
the subtances must present reduced IC50 value assays, 
minimizing the lack of drug specifity and side effect (de 
Souza et al. 2017). Extract have IC50 value ≤ to P. falcifarum 
can be continued to isolation of active compounds in 
medicinal plant (Oliveira et al. 2014). Ethyl acetate G. 
husor stem bark extract showed reduced IC50 value (0.31 
μg/ml) against P. falcifarum 3D7 strain. Moreover, it is 
expected that a potent antimalarial agent (Katusno et al. 
2015) and be continue in vivo antimalaria assay. 
The present results shown a low toxicity of ethyl 
acetate extract even at doses higher than used in the 
study. The absence of clinical features of toxicity or 
weight variation is important, mainly because in 
the malaria state the animal can present symptoms 
belonging to both states such as pelage change, lethargy 
and weight loss which could interfere which the results. 
The observation that no death caused by an oral 
highest dose of 200 mg/kg body weight of ethyl acetate 
extract of the G. husor stem bark could imply the safety 
of the plant to be used in the treatment of Malaria as also 
suggested in Akele et al. 2013 and Murithi et al. 2014. The 
acute toxicity result of the present study suggested that 
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Figure 3. Reduce of parasitemia (%). Each bar represents the mean ± SD reduce parasitemia of animal belonging to G1 (of 
P. berghei infected-mice), G2 to G4 (ethyl acetate G. husor extract 10, 100, and 200 kg/BW), respectively). IUE: 
infected untreated of extract; ITE: Infected treatment extract, AD: average of difference. Significantly different 
(p<0.05) inreduce of parasitemia of G1 compared to G2-G4
Figure 4. Microscopic evidence of erythrocytic is infected with P. berghei after treatment antimalarial activity of G. husor 
extract. Infected erythrocytes (trofozoite ring form) are indicated by arrows. (a) dose 10 mg/kg BW, (b) dose 100 
mg/BW, (c) Dose 200 mg/BW
a b c
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the oral extract at the highest dose (200 mg/kg BW) and 
included in the category of practically non-toxic (OECD 
2008). The experimental determination of acute toxicity 
at the extract dose of up to 2000 mg/kg body weight 
of mice may justify the use of this plant for malaria 
treatment.  
In vivo antiplasmodial activity can be classified as 
moderate, good and very good if an extract displayed 
a respective percent parasite suppression equal to or 
greater 50% at doses of 500, 250, and 100 mg/kg body 
weight per day (Munoz et al. 2000; Deharo et al. 2001). 
Based on this classification, the extract of G. husor are 
considered to exhibit good antiplasmodial activity, with 
dose dependent inhibition against P. berghei infection 
in mice.
Malaria is an inflammatory cytokine-driven disease 
that often results in mortality due to sequestered 
parasitized red cells preventing sufficient oxygen access 
to where it is needed together with mitochondria 
inability to generate enough adenosine triphosphate to 
maintain normal cellular function (Clarck et al. 2010). 
P. berghei parasite is used in predicting treatment 
outcomes of any suspected antimalarial agent due 
to its high sensitivity to chloroquine, making it the 
appropriate parasite for this study (Boampong et al. 
2015). In this study, three doses of the ethyl acetate 
stem bark extracts of G. husor exerted curative 
antimalarial activities against the blood stage of 
P. berghei. Ethyl acetate extract give high effect for 
reduce level of parasitemia in dose 100 mg/kgBW 
24±0.01% and 87.37±1.41% inhibition of parasite of P. 
berghey–infected mice. This result showed that effect 
ethyl acetate extract lower than treated orally dose 
100 mg/kg BW with artemisinin were 54±0.14%; 95%, 
respectivelly (de Souza et al. 2017).  This implies that the 
active principles for the observed antimalarial effects 
are present in ethyl acetate extract. It is proposed that 
the presence of alkaloids, triterpenoids, flavonoids, 
phenolics, and  tannins could be responsible for the 
observed curative antiplasmodial activities of the 
extract but further experiments are needed to confirm 
this hypothesis. Some alkaloids that act against malaria 
parasites inhibit protein synthesis by intercalating with 
DNA of the parasite (Okokon et al. 2008; Christian et al. 
2012). In addition, flavonoids and tannins have been 
suggested to act as primary antioxidants or free radical 
scavengers that can counteract the oxidative damage 
induced by the malaria parasite (Gautam et al. 2011; 
Kayani et al. 2016). Numerous studies have implicated 
oxidative stress in several pathological conditions such 
as stroke, diabetes, Parkinson's disease and so on. Apart 
from their detrimental effects, free radicals are also 
involved in cellular signaling and as carriers for iron 
requirement needed by parasites for survival in a host. 
Iron is a crucial nutrient for survival and replication of 
microorganisms such as Plasmodium parasites. Thus, 
the ability of an antioxidant to chelate/sequester iron 
needed by the Plasmodium parasite will adversely 
affect the survival of the parasite in a host. Flavonoids 
in particular have the ability to chelate iron and they 
have been suggested that such compounds with 
the ability to sequester iron should be employed in 
treatment of infections (Chandrashekaran et al. 2010). 
Ethyl acetate extract have high total flavonoid content, 
which possibly contributed to the antiplasmodial 
effect observed in the mice. Some terpenoids attack the 
broadest age range of parasites, from the tiniest rings 
that have recently invaded erythrocytes to more mature 
stages of parasites such as developing trophozoites 
and schizonts. Their relatively broad stage-specificity 
of action has been reported to extend to the ability to 
impede development of gametocytesm (Yoo et al. 2008; 
Coma-cros et al. 2018). The data provide evidence that 
stem bark extracts of G. husor antiplasmodial activity 
which may partly be mediated by its phytochemical 
compounds. 
In the qualitative and quantitative analysis of this 
plant studied, some of these secondary metabolites 
were present and saponin was absent. It has been 
reported that several plant constituents, vis; flavonoid, 
tannins, xanthone, phenolic, and triterpenoid posses 
protein-binding and enzim-inhibiting properties 
(Selvanayagam and Ghanavendhan 1995; Fale et al. 
2012; Oluwatosin  et al. 2014). The likely mechanism of 
action of this extract contain flavanoid may be inhibition 
of key pathognic enzymes of the parasite since extract 
is known to interference with enzymes sistem (Okunji 
et al. 2007; Penduka et al. 2011). Alkaloids are important 
phytochemicals, that are said to be pharmacologically 
active. Quinine, an alkaloid, is popular for is antimalaril 
activity against the malaria parasite (Bankole et al. 
2016). Triterpen, 3b-hydroxy-23-oxo-9,16-lanostadien-
26-oic acid or garcihombronane D from G. celebica 
showed a selective activity against P. falcifarum (Elfita 
et al. 2009).
Pearson’s correlation coefficient (r) showed high 
and positive correlation between phenolic content 
in extract with antimalarial activity (Table 3). In the 
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present study, TPC and TFC to be analytical markers 
since they were the major components of the test 
sample. Similarly, phenolic were have confirmed its 
antimalarial activity. On the other hand, due to the 
complexity of the sample, it is difficult to state that 
molecule is responsible for the antimalarial potential 
of extract, with a synergistic effect probably playing an 
important role in the activity. 
The previous studies reported that phenolic 
components from Garcinia genus have antimalarial 
potential i.e. α and β-mangostin (G. mangostana) 
1,5-dihidroksi-3,6-dimetoksi-2,7-diprenilsanton 
isosantoximol (G. griffithii), kolaviron (G. cola) 
(Mahabusarakham et al. 2006; Oluwatusin et al. 2014). 
Malaria infection also causes renal damage due 
to high parasitemia, when parasitized erythrocytes 
become hard, with reduced deformability and changes 
conformation. This increases blood viscosity, slowing 
and microcirculation and altering renal blood flow. 
Additionally, the cytoadherence of infected erythrocytes 
alters the local circulation, aggravating the renal injury. 
Our result showed that treatment with extract may 
contribute to an increase in the microcirculation, 
reducing erythrocyte cytoadhence, with a significant 
decrease of parasitemia.
The present study revealed that ethyl acetate stem 
bark G. husor extract effective herb with significant 
antiplasmodium in vitro test antiplasmodium against 
P. falcifarum 3D7 strain and in vivo test in M. musculus 
infected P. berghei (ANKA) strain. The biological 
activities observed in the study could be attributed 
to the higher phenolic and flavonoid contents of the 
extract. The result obtained in this study demosntrated 
that the ethyl acetate of G. husor stem bark extract 
potent antimalaria activity. However, this appears to 
the first report of antimalarial properties of stem bark 
G. husor extract in vitro and in vivo research. The result 
of this study suport the traditional claim of the plant in 
the use for malaria treatment, and effort are currently 
underway to identify the bioactive components of the 
plant and toxicological effects in animals. 
The overall, result showed that ethyl acetate of G. 
husor stem bark in vitro and in vivo has good activities 
as antipalsmodial. Furthermore that can be used as 
antimalarial drugs alternative or as a combination with 
antimalarials other. 
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